Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Rheumatology | Nephrology/Urology
Disease Category: Gout (Hyperuricemia)
Trial Information
Gout
Ridgeview Research is participating in a clinical research study for an investigational medication. This medication will be compared to a commonly used marketed medication. There is no placebo (inactive substance).
Study Length:
14 days
# Visits:
8 days of study medication
Patient Inclusion Criteria:
- 18 years of age or older
- History of gouty arthritis or current symptoms of gout.
- Females must be postmenopausal, surgically sterile or using birth control since their last period prior to start of study and during the study.
Patient Exclusion Criteria:
- Diagnosis of any other type of arthritis
- Any sensitivity to previously taken NSAIDs (aspirin, ibuprofen, naproxen)
- Have had a stroke or have any other heart conditions
Ridgeview Research
3000 Hundertmark Road
Chaska, MN 55318
Phone: (952) 556-2687
Fax: (952) 556-2688
EMail: kristy.swanson@ridgeviewmedical.org
View Google Map
Research Center Information: Ridgeview Research
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
